Page 5,325«..1020..5,3245,3255,3265,327..5,3305,340..»

Pharmacy dean rallies students

Posted: Published on May 12th, 2013

By COLIN M. STEWART Tribune-Herald staff writer Dean John Pezzuto conveyed Friday a sense of determination paired with lingering shellshock as he updated students and faculty on the Daniel K. Inouye College of Pharmacys failed campaign to fund a permanent building this Legislative Session. Obviously, we have experienced a little adversity, but that has strengthened our shared vision of building a world-class program, he said Friday afternoon to a gathering of about 300 members of the College of Pharmacy community. The crowd listened intently as he spoke and answered questions for about 45 minutes, despite the discomfort of being packed onto the wooden bleachers of the University of Hawaii at Hilos gymnasium, a situation Pezzuto called a testament to the fact that we need a new building. One of the foremost questions on everyones minds since the completion of the session has been Why wasnt the building funded? Pezzuto said. As I continue to get more mature, Ive learned more about myself, that I have more patience than when I was younger, he said. Ive come to a conclusion that there are some things Ill never be able to understand or know the answer to. Now, youve heard that our … Continue reading

Posted in Pharmacy | Comments Off on Pharmacy dean rallies students

Héma-Québec appeals for more black stem cell donors

Posted: Published on May 11th, 2013

Hma-Qubec is working with members of Montreal's black community to increase the number of blood and stem cell donors. Qubc's black community is chronically underrepresented in blood banks and on the bone marrow transplant registry, making treatment more challenging for black patients. "A lot of times people suffer from sickle cell anemia, and there are not enough donors from our ethnicity that give, so I think it's just a good way of helping out other people," said Mitchum Burnett, who gave blood for the fifth time on Friday. He discovered all it takes is a cheek swab to register as a stem cell donor. Yet of more than 39,000 Quebecers registered as stem cell donors, only 89 are black Quebecers. Tamu Townsend got involved in drives like the one held on Friday after her brother Emru was diagnosed with leukemia. He died after a long-sought transplant didn't work. "One thing I realized was drives for blood and for stem cells increase a lot of awareness," Townsend said. "In fact, I'm registered as a stem cell donor because of my brother's illness." Naderge Ceneston, a nurse with Hma-Qubec who is also black, said people in the black community need to be … Continue reading

Comments Off on Héma-Québec appeals for more black stem cell donors

Outgrowing autism

Posted: Published on May 11th, 2013

BACKGROUND: Autism spectrum disorder (ASD) and autism are both general terms for a group of complex disorders of brain development. These disorders are characterized, in varying degrees, by difficulties in social interaction, verbal and nonverbal communication, and repetitive behaviors. They include autistic disorder, Rett syndrome, childhood disintegrative disorder, pervasive developmental disorder-not otherwise specified (PDD-NOS) and Asperger syndrome. (SOURCE: http://www.autismspeaks.org/what-autism) CAUSES: Autism is a physical condition linked to abnormal biology and chemistry in the brain. The exact causes of these abnormalities remain unknown, but this is a very active area of research. There are probably a combination of factors that lead to autism. A number of other possible causes have been suspected, but not proven. They involve: (SOURCE: http://www.ncbi.nlm.nih.gov/pubmedhealth/) SYMPTOMS: Most parents of autistic children suspect that something is wrong by the time the child is 18 months old and seek help by the time the child is age two. Children with autism typically have difficulties in pretend play and social interaction. A number of children with an ASD do not like cuddling or being touched like other children do. ASD symptoms may vary from moderate to severe; the higher the severity of the autism, the more affected are a person's … Continue reading

Comments Off on Outgrowing autism

Scheme will cover cost of autism treatment

Posted: Published on May 11th, 2013

Disability Reform Minister Jenny Macklin: Declared the NDIS will cover "most" people with autism. Photo: Alex Ellinghausen The national disability insurance scheme will cover ''most'' people with autism and could pay the full cost of early intervention programs, Disability Reform Minister Jenny Macklin has declared in the latest clue as to what the $22 billion-a-year scheme will cover. Autism affects about one in 100 children in Australia. Diagnoses of the condition more than doubled in Australia from 2003 to 2009 - 64,000 Australians have autism, latest figures show. There were fears that the condition would be excluded from the scheme, or that the support provided by DisabilityCare Australia would be no greater than the current program, which funds only a fraction of the cost of the most effective therapies. Opposition Leader Tony Abbott has demanded the government clarify whether autism will be included in the scheme, but ministers have only pointed to the legislation passed in March, which set broad parameters. Advertisement But in an interview with Fairfax Media, Ms Macklin confirmed the scheme would support ''most'' people with autism but stressed the agency would work with people to identify their individual needs. ''People are very different, they have very … Continue reading

Comments Off on Scheme will cover cost of autism treatment

Govt stops study seeking to prevent type of stroke

Posted: Published on May 11th, 2013

WASHINGTON (AP) The government has halted a study testing treatments for a brain condition that can cause strokes after early results suggested invasive therapies were riskier than previously thought. The condition involves a kind of tangle in the brain called an arteriovenous malformation, or AVM. Arteries and veins grow knotted together until eventually some of them burst, causing a bleeding stroke. AVM accounts for a small fraction of hemorrhagic strokes. But increasingly, brain scans can spot these tangles well before they're at risk of bleeding raising the question of what to do for patients, if anything. The study aimed to tell if treating them could prevent a stroke later in life. Early results suggest it may be safer to leave the condition alone, said Columbia University neurologist Dr. Jay Mohr, who helped lead the study. Nearly three years into the research, the rate of strokes and death was more than three times higher among participants who had received surgery, radiation or other invasive treatment than among patients given medication for headaches and other symptoms. Mohr couldn't provide precise numbers but said most of the cases were strokes and there were very few deaths. "From what we can see, our current … Continue reading

Comments Off on Govt stops study seeking to prevent type of stroke

Research and Markets: Neuromodulation Market Research Report Forecasts to 2017 – Neuromodulation emerging as one of …

Posted: Published on May 11th, 2013

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/rmlhjl/neuromodulation) has announced the addition of the "Neuromodulation Market - [Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), & Transcranial Magnetic Stimulation (TMS)] - Forecasts to 2017" report to their offering. The main drivers for the neuromodulation market are the rising population of aged people and age-related diseases like Alzheimer's, epilepsy, spinal cord injury, and Parkinson's disease. According to the International Neuromodulation Society, about 40 million to 50 million patients worldwide suffer from epilepsy, and 1.5 million people currently (2012) suffer from Parkinson disease in the U.S. The large pool of patients that suffer from depression, stroke, anxiety disorders, lower back pain, urinary incontinence, and tremor offers the neuromodulation industry opportunities to grow in the next five years. The market for treatment of tinnitus, in particular, represents an emerging application of neuromodulation. According to the American Tinnitus Association, about 50 million people currently (2012) suffer from this disease in the U.S. Neuromodulation devices have emerged as one of the fastest growing segments of the medical device market due to high demand for minimally invasive and non-invasive treatment. With advancements in technology, neuromodulation is … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Research and Markets: Neuromodulation Market Research Report Forecasts to 2017 – Neuromodulation emerging as one of …

AskPatty.com and National MS Society Launch Joint MOMS Campaign to Raise Awareness for Multiple Sclerosis

Posted: Published on May 11th, 2013

Thousand Oaks, CA (PRWEB) May 10, 2013 AskPatty.com Inc., a website, blog, and online resource that serves as a safe haven for women to get advice on car purchases, preventative maintenance and repairs, and other automotive related topics, is pleased to announce that they will be running a month-long campaign along with the National MS Society to raise funds and awareness for MS, an illness that has affected AskPatty.com CEO Jody DeVere's family personally. Multiple sclerosis is a chronic, often disabling disease that attacks the central nervous system, which is made up of the brain, spinal cord, and optic nerves. Symptoms may be mild, such as numbness in the limbs, or more severe, causing paralysis or loss of vision. The progress, severity, and specific symptoms ofMS are unpredictable and vary from one person to another. Today, new treatments and advances in research are giving new hope to people affected by the disease. Jody DeVere, CEO ofAskPatty.com, is a mom with two adult children fighting Multiple Sclerosis. Jody's son Joe, now 40, has been fighting MS since 2002 and has a spinal cord injury due to a car accident in 2005 related to hisMS. Joe is currently in theSecondary Progressivestage of … Continue reading

Posted in MS Treatment | Comments Off on AskPatty.com and National MS Society Launch Joint MOMS Campaign to Raise Awareness for Multiple Sclerosis

Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss First Quarter 2013 Financial Results

Posted: Published on May 11th, 2013

THE WOODLANDS, Texas--(BUSINESS WIRE)-- Opexa Therapeutics, Inc. (OPXA), a leader in developing a patient specific T-cell immunotherapy for multiple sclerosis (MS), today announced that the company will report financial results for the three months ended March 31, 2013, before the opening of trading on Tuesday, May 14th. The company will also conduct a conference call and webcast to discuss financial results and provide a corporate update at 8 A.M. Eastern Time on Tuesday, May 14th. Conference Call and Webcast Details To listen to the conference call, dial in approximately ten minutes before the scheduled 8 AM time to (253) 237-1170 or toll free at (877) 372-0867. Please reference conference ID # 70924987 while dialing into the call. A live webcast of the call can also be accessed via the webcast link on our website (www.opexatherapeutics.com) or by going to the following URL: http://investor.shareholder.com/media/eventdetail.cfm?eventid=129946&CompanyID=OPXA&e=1&mediaKey=52AF10A2390CE08BC8D2847172A3B20C There will be a brief Question & Answer session following management commentary. Share holders and interested parties are highly encouraged to submit questions in advance by e-mail addressed to kradhakrishnan@opexatherapeutics.com. About Opexa Opexas mission is to lead the field of precision immunotherapy by aligning the interests of patients, employees and share holders. The Companys leading therapy candidate, … Continue reading

Posted in MS Treatment | Comments Off on Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss First Quarter 2013 Financial Results

Dr. Gary M. Levin's Multiple Sclerosis Treatment Review and MS Research Revealed by SclerosisTreatment.com

Posted: Published on May 11th, 2013

Denver, Colorado (PRWEB) May 10, 2013 According to http://www.SclerosisTreatment.com researchers are looking at MS every conceivable way taught by medicine, and although the FDA has approved several drug-based treatments, there isnt a permanent cure for the condition. The Multiple Sclerosis Treatment by Dr. Gary M. Levin uses a step-by-step method that rehabilitates your immune system and boosts your supporting body systems to rid it of all symptoms. The keys are correct nutrition, healthy diet and potent herbs that empower the impacted immune system to act within normal parameters instead of wreaking havoc. No drug provides a cure for multiple sclerosis so it is important to have a variety of treatment options available for patients. Multiple sclerosis can impair movement, sensation, and thinking and have a profound impact on a persons quality of life, reads a statement by Russell Katz, M.D., director of the Division of Neurology Products in the FDAs Center for Drug Evaluation and Research. With that picture in mind, it is easy to understand why MS patients are appealed by natural treatments for MS, e-books that sell for a tiny fraction of a full-drug therapy that give the patient herbal therapies to manage their condition. Dr. Gary M. … Continue reading

Posted in MS Treatment | Comments Off on Dr. Gary M. Levin's Multiple Sclerosis Treatment Review and MS Research Revealed by SclerosisTreatment.com

HRT Won't Dull Your Brain

Posted: Published on May 11th, 2013

New research has examined the cognitive effects of hormone therapy on memory, language, and concentration in menopausal women. The study, published in the journal Menopause, examined the effects of HRT E2D, a combination of the hormones estradiol and drospirenone. Early postmenopausal women aged between 49 and 55 who had never used HRT were assessed over a six-month period. According to a release from Monash University in Australia where the research was conducted, Professor Susan Davis noted that there had long been debate about the safety of hormone replacement therapies and the potential adverse effects on cognitive function in women. These findings are reassuring for women, Professor Davis said. We report, for the first time, that drospirenone combined with estradiol has no overall effect on the cognitive performance of postmenopausal women examined over a 26-week period. Although hormone replacement therapy is no quick fix to the challenge of menopause, it does show that the E2D treatment can be useful in the overall management of menopause, and without adversely effecting cognitive ability. Copyright 1997 - 2013 ThirdAge Media, LLC. All rights reserved. Visit link: HRT Won't Dull Your Brain … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on HRT Won't Dull Your Brain

Page 5,325«..1020..5,3245,3255,3265,327..5,3305,340..»